Citations

Showing 10 of 108104 citations.

Ten-Year Risk Factors for Inferior Knee Injury and Osteoarthritis Outcome Score After Anterior Cruciate Ligament Reconstruction: A Study of 874 Patients From the Swedish National Knee Ligament Register
Senorski, Eric Hamrin , Svantesson, Eleonor , Sundemo, David , Westin, Olaf, Samuelsson, Kristian , Alentorn-Geli, Eduard, Samuelsson, Kristian , Hamrin Senorski, Eric , Spindler, Kurt P , Alentorn‐Geli, Eduard , Karlsson, Jón

Mayo Clinic

The American Journal of Sports Medicine | August 13, 2018 | Volume: 46 | Issue: 12 | Pages: 2851-2858

10.1177/0363546518788325 | PMID 30102869 Get It

Background: Factors relating to the patient and anterior cruciate ligament (ACL) reconstruction may help to identify prognostic factors of long-term outcome after reconstruction. Purpose: To determine 10-year risk factors for inferior knee function after ACL reconstruction. Study Design: Cohort study; Level of evidence, 2. Methods: Prospectively collected data from the Swedish National Knee Ligament Register were extracted for patients who underwent ACL reconstruction between January 2005 and December 2006. Patients who had no data at the 10-year follow-up for the Knee injury and Osteoarthritis Outcome Score (KOOS) were excluded. Multivariable proportional odds regression modeling was used to assess 10-year patient- and surgery-related risk factors across all the KOOS subscales and the KOOS 4 (mean score of 4 subscales: pain, knee-related symptoms, function in sport and recreation, and knee-related quality of life). Results: A total of 874 (41%) patients were included (male, 51.5%; median age at the time of ACL reconstruction, 27.5 years [range, 11.2-61.5 years]). An increase in the severity of concomitant articular cartilage injuries resulted in a reduced KOOS on 4 subscales (odds ratio, 0.64-0.80; P < .05). A higher preoperative KOOS pain score increased the odds of a higher score on the pain, symptoms, and sport subscales and the KOOS 4 . In addition, a higher preoperative body mass index was a significant risk factor for lower scores on 3 KOOS subscales and the KOOS 4 . No patient- or surgery-related predictor was significant across all KOOS subscales. Conclusion: This 10-year risk factor analysis identified several factors that can affect long-term knee function after ACL reconstruction. Most risk factors were related to preoperative patient-reported outcome and potentially modifiable. On the other hand, most of the surgery-related risk factors were nonmodifiable. Nevertheless, this information may be helpful to physicians and physical therapists counseling patients on their expectations of outcome after ACL reconstruction.
Evaluation of the Bio-Rad BioPlex 2200 Toxoplasma gondii IgM Multiplex Flow Immunoassay
Theel, Elitza S. , Hilgart, Heather, Gronowski, Ann M., Yarbrough, Melanie L.

Mayo Clinic

The Journal of Applied Laboratory Medicine | August 13, 2018 | Volume: 3 | Issue: 6 | Pages: 1022-1027

10.1373/jalm.2018.026906 | PMID 31639693 Get It

Abstract Background Toxoplasmosis is routinely diagnosed through detection of Toxoplasma gondii–specific antibodies. However, the imperfect specificity of T. gondii serologic assays is a well-recognized limitation. The new BioPlex 2200 (Bio-Rad Laboratories) T. gondii, rubella, and cytomegalovirus (ToRC) IgM multiplex flow immunoassay (MFI) received FDA clearance in May 2017. We evaluated the clinical performance of the new T. gondii IgM and existing IgG portion of this MFI. Methods Three hundred prospectively collected consecutive, residual sera, submitted for T. gondii serologic testing as part of routine clinical care, and an archived set of 52 residual sera previously positive for anti–T. gondii IgM and IgG with the predicate ADVIA Centaur Toxoplasma IgM and IgG assays (Siemens) were evaluated. Performance of the BioPlex 2200 T. gondii IgM and IgG MFIs was assessed by calculating positive (PPA) and negative percent agreement (NPA) compared to the Centaur tests. Results Among prospective specimens, the BioPlex 2200 T. gondii IgM and IgG MFIs demonstrated a PPA of 0% (0/7) and 82.3% (28/34) and NPA of 99.3% (288/290) and 95.8% (251/262), respectively, with the Centaur assays. Chart review of the 7 Centaur T. gondii IgM-positive samples revealed that these were likely falsely positive. Among archived samples, the BioPlex 2200 T. gondii IgM and IgG MFIs showed PPAs of 90.4% (47/52) and 100% (52/52), respectively. Conclusions The BioPlex 2200 T. gondii IgM and IgG MFIs demonstrated excellent concordance with the Centaur assays. The T. gondii IgM MFI may provide higher specificity in low-prevalence populations.
The Association of Multimorbidity With Preclinical AD Stages and SNAP in Cognitively Unimpaired Persons
Vassilaki, Maria , Aakre, Jeremiah A. , Kremers, Walter K. , Geda, Yonas E. , Alhurani, Rabe E., Dutt, Taru , Vemuri, Prashanthi , Coloma, Preciosa M. , Schäuble, Barbara, Lowe, Val J. , Jack, Clifford R. , Petersen, Ronald C. , Roberts, Rosebud O., Jack, Clifford R , Vemuri, Prashanthi , Geda, Yonas E , Kremers, Walter K , Mielke, Michelle M. , Machulda, Mary M. , Knopman, David S.

Mayo Clinic

The Journals of Gerontology: Series A | August 13, 2018 | Volume: 74 | Issue: 6 | Pages: 877-883

10.1093/gerona/gly149 | PMID 30124772 Get It

An Increase in Chromogranin A-Positive, Hormone-Negative Endocrine Cells in Pancreas in Cystic Fibrosis
Cory, Megan , Moin, Abu Saleh Md , Moran, Antoinette , Rizza, Robert A., Dhawan, Sangeeta , Butler, Alexandra E. , Butler, Peter C. , Dhawan, Sangeeta

Mayo Clinic

Journal of the Endocrine Society | August 13, 2018 | Volume: 2 | Issue: 9 | Pages: 1058-1066

10.1210/js.2018-00143 | PMID 30202828 Get It

Lentil (Lens culinaris Medikus) Diet Affects the Gut Microbiome and Obesity Markers in Rat
Siva, Niroshan , Johnson, Casey R. , Jesch, Elliot D., Abood, Abdullah , Thavarajah, Pushparajah, Thavarajah, Dil , Thavarajah, Dil , Richard, Vincent J. , Whiteside, William Scott , Duckett, S. K.

Mayo Clinic

Journal of Agricultural and Food Chemistry | August 13, 2018 | Volume: 66 | Issue: 33 | Pages: 8805-8813

10.1021/acs.jafc.8b03254 | PMID 30102041 Get It

Orthostatic Hypotension as a Prodromal Marker of α-Synucleinopathies—Reply
Savica, Rodolfo , Mielke, Michelle M. , Mielke, Michelle M , Boeve, Bradley F.

Mayo Clinic

JAMA Neurology | August 13, 2018 | Volume: 75 | Issue: 9 | Pages: 1155

10.1001/jamaneurol.2018.2251 | PMID 30105350 Get It

The Osteoinductive Effect of Controlled Bone Morphogenic Protein 2 Release Is Location Dependent
Olthof, Maurits G.L. , Lu, Lichun , Tryfonidou, Marianna A. , Loozen, Loek D. , Pouran, Behdad , Yaszemski, Michael J. , Meij, Björn P. , Dhert, Wouter J.A. , Alblas, Jacqueline , Kempen, Diederik H.R.

Mayo Clinic

Tissue Engineering Part A | August 13, 2018 | Volume: 25 | Issue: 3-4 | Pages: 193-202

10.1089/ten.tea.2017.0427 | PMID 30101676 Get It

The main challenge in bone morphogenic protein 2 (BMP-2)-based application lies in finding strategies that prolong its effective period as it has a short biological half-life. Several BMP-2 release profiles have shown to enhance bone formation at various application sites. However, it remains to be determined which BMP-2 release profile best augments bone formation and whether this effect is location dependent. Therefore, the aim of this study was to investigate the effect of BMP-2 release from oligo[(polyethylene glycol) fumarate] bis(2-(methacryloyloxy)ethyl) phosphate (OPF-BP) composites on the osteoinductive efficacy at ectopic versus orthotopic application. By varying the BMP-2 loading method, three different OPF-BP composites were created with varied release profiles. The composites were compared with unloaded OPF-BP as negative control, and to the clinically used Infuse ® absorbable collagen sponge (ACS) as positive control. Bone formation was assessed by microcomputed tomography after 9 weeks of subcutaneous implantation and 3, 6, and 9 weeks of orthotopic implantation in rats ( n = 48). Whereas a BMP-2 burst release of >49% generated significantly more bone compared with sustained release (burst release <30%) at the subcutaneous implantation site, differential release did not affect bone formation at the orthotopic site. Furthermore, all BMP-2 containing OPF-BP composites showed significantly more bone formation compared with ACS in the orthotopic implantation site. In conclusion, this study clearly shows that the osteoinductive effect of different BMP-2 release profiles is location dependent. In addition, more bone formation in OPF-BP compared with ACS at both application sites emphasizes the role of biomaterials as a scaffold to achieve proper bone tissue formation. Impact Statement The main challenge in bone morphogenic protein 2 (BMP-2)-based application lies in finding strategies to prolong its biologic activity as it has a short biological half-life. The present study uses a phosphate-modified oligo[(polyethylene glycol) fumarate] hydrogel that can be tuned to achieve differential release profiles of biologically active BMP-2 release. We demonstrate that this platform outperforms Infuse ® , currently used in the clinic and that the osteoinductive effect of BMP-2 is location dependent. Altogether, this study stresses the importance of evaluating efficacy of bone tissue engineering strategies at an orthotopic location rather than subcutaneously. Even more so, it emphasizes the role of biomaterials as a scaffold to achieve proper bone tissue engineering.
Nutrition and Inflammatory Biomarkers in Chronic Pancreatitis Patients
Greer, Julia B., Greer, Phil J. , Sandhu, Bimaljit S., Alkaade, Samer, Wilcox, C. Mel , Anderson, Michelle A. , Sherman, Stuart , Gardner, Timothy B. , Lewis, Michele D. , Guda, Nalini M. , Muniraj, Thiruvengadam , Conwell, Darwin L. , Coté, Gregory A. , Forsmark, Christopher E., Banks, Peter A. , Tang, Gong , Stello, Kim, Gelrud, Andrés , Slivka, Adam, Whitcomb, David C. , Yadav, Dhiraj , Whitcomb, David C , Lewis, Michele D , Brand, Randall E.

Mayo Clinic

Nutrition in Clinical Practice | August 13, 2018 | Volume: 34 | Issue: 3 | Pages: 387-399

10.1002/ncp.10186 | PMID 30101991 Get It

Abstract Background Chronic pancreatitis (CP) patients frequently experience malabsorption and maldigestion, leading to micronutrient and macronutrient deficiencies. Comorbid diabetes and lifestyle habits, such as alcohol consumption, may impact nutrition status. Methods We compared micronutrient antioxidant, bone metabolism, serum protein, and inflammatory marker levels in 301 CP patients and 266 controls with no known pancreatic disease. We analyzed serum prealbumin and retinol binding protein; vitamins A, D, E, and B12; osteocalcin; tumor necrosis factor‐α; and C‐reactive protein (CRP). We also evaluated biomarkers among subsets of patients, examining factors including time since diagnosis, body mass index, alcohol as primary etiology, diabetes mellitus, vitamin supplementation, and pancreatic enzyme replacement. Results After correcting for multiple comparisons, CP patients had significantly lower levels than controls of the following: vitamin A (40.9 vs 45.4 μg/dL) and vitamin E (α‐tocopherol [8.7 vs 10.3 mg/L] and γ‐tocopherol [1.8 vs 2.2 mg/L]), as well as osteocalcin (7.9 vs 10 ng/mL) and serum prealbumin (23 vs 27 mg/dL). Both patients and controls who took vitamin supplements had higher serum levels of vitamins than those not taking supplements. Compared with controls, in controlled analyses, CP patients had significantly lower levels of vitamins A, D, and E (both α‐tocopherol and γ‐tocopherol). CP patients also had significantly lower levels of osteocalcin, serum prealbumin, and retinol binding protein, and higher CRP. Conclusions CP patients demonstrated lower levels of selected nutrition and bone metabolism biomarkers than controls. Diabetes and alcohol did not impact biomarkers. Vitamin supplements and pancreatic enzyme replacement therapy improved nutrition biomarkers in CP patients.